Airways inflammation is a complex biological phenomenon resulting from the recruitment and activation of numerous cell types. This book provides a collection of valuable reviews on the major inflammatory cells involved in airways disease and examines the pharmacology of current anti-inflammatory drugs used in the treatment of airways disease.

Contents. List of Contributors. Preface. Peter K. Jeffery: Pathological spectrum of airway inflammation. Gianni Marone, Anna Ciccarelli, Giuseppe Spadaro and Anna Maria Onorati: Role of basophils in airways inflammation. Paolo Gresele and Roberta Vezza: Platelets. Moira Whyte: Neutrophils. Anthony J. Coyle, Jose Carlos Gutierrez-Ramos: Eosinophils in asthma. Ian A. Akers, Robin J. McAnulty and Geoffrey J. Laurent: Fibroblasts and myofibroblasts. Elaine Lee and Stephen A. Kilfeather: Airway macrophages and dendritic cells. Anne Burke-Gaffney and Paul G. Hellewell: Contribution of endothelial cells to airway inflammation. Jagdish Laxman Devalia, Jia Hua Wang and Robert James Davies: Airway epithelial cells. Alastair G. Stewart, Darren J. Fernandes, Valentina Kalafatis, Aurora Messina, Claire E. Ravenhall, Ross Vlahos and Kai-Feng Xu: Airway smooth muscle cells. K. H. Banner, D. Spina and C. P. Page: Drugs that reduce airways inflammation. D. M. Kemeny and B. J. O`Connor: T cells in the lung. Index.

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com